Skip to main content
. Author manuscript; available in PMC: 2018 Aug 1.
Published in final edited form as: Clin Ther. 2017 Jul 26;39(8):1537–1549. doi: 10.1016/j.clinthera.2017.07.002

Table 2.

Immune Correlates of Protection From Human Noroviruses

Immune Correlate Prevention of or reduction
in clinical illness
Prevention of or
reduction in
documented infection
References
Serum HBGA-blocking antibody 24, 63
Serum hemagglutination inhibition antibody 23
NV-specific salivary IgA 26
NV-specific fecal IgA 26
NV-specific memory IgG cells 26